Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Golden Omega is a leading Chilean producer of high-quality Omega-3 concentrates, specializing in EPA and DHA ingredients for the nutraceutical and pharmaceutical industries. The company operates a state-of-the-art manufacturing facility in Arica, Chile, which utilizes advanced molecular distillation and patented purification processes to ensure high purity and low oxidation. As a joint venture between Orizon and Corpesca, Golden Omega maintains a vertically integrated supply chain, providing full traceability from the sustainable fisheries of the South Pacific to the final product. Their portfolio includes a wide range of concentrations tailored for cardiovascular, cognitive, and overall health applications. The company is recognized globally for its commitment to quality, sustainability, and innovation in the marine oil sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Golden Omega.